Assessing Health Technology in the EU: Commission Proposes to Reinforce Cooperation Amongst Member States
European Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. Greater transparency will empower patients, by ensuring their access to information on the added clinical value of new technology that could potentially benefit them.
Read more ...
Augmented Reality System Lets Doctors See under Patients' Skin without the Scalpel
New technology is bringing the power of augmented reality into clinical practice. The system, called ProjectDR, allows medical images such as CT scans and MRI data to be displayed directly on a patient's body in a way that moves as the patient does.
Read more ...
Hamlyn Centre Announces Grant from Bill & Melinda Gates Foundation for Development of Dietary Intake Monitoring Technology
The Hamlyn Centre at Imperial College London today announces the award of a grant from the Bill & Melinda Gates Foundation, to accelerate research into new integrated technology systems for accurately measuring dietary intake. The grant of $1.5M will fund key investigation projects until April 2020, supporting the research and development of passive dietary intake monitoring tools and wearables that can support nutritional studies in low and middle-income countries.
Read more ...
West of Scotland Creates Regional Portal
Scottish health boards covering a population of 2.2 million people are able to share patient information now that a two-year project to create a regional portal has been completed. Five West of Scotland health boards are covered by the project to link their Orion Health portals, with NHS Dumfries and Galloway the latest to join in July. Clinicians can now click on a simple link within their own health board's portal to access the regional portal links, from where they can view test results and other information.
Read more ...
FDA Approves Pill with Sensor that Digitally Tracks if Patients Have Ingested their Medication
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
Read more ...
Smartphone Apps Launched for Atrial Fibrillation Patients and their Healthcare Providers
Novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace,(1) with a summary published in the European Heart Journal.(2)
Read more ...
NHS 'Will be Hit by More Cyber Attacks'
Concern about NHS cyber security has increased following the WannaCry attack and healthcare management professionals expect it to come under further attack from "organised hacktivists", according to a new survey of those registered to attend this year's UK Health Show. The survey of almost 600 registrants to the show, which is held at Olympia London on 27 September, suggests that leading managers and professionals are very worried about similar cyber attacks in the future.
Read more ...
European Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. Greater transparency will empower patients, by ensuring their access to information on the added clinical value of new technology that could potentially benefit them. 
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.